The replication-competent HIV reservoir is a genetically restricted, younger subset of the overall pool of HIV proviruses persisting during therapy, which is highly genetically stable over time.

HIV genetic stability molecular dating persistence phylogenetics rebound

Journal

Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724

Informations de publication

Date de publication:
12 Jan 2024
Historique:
medline: 12 1 2024
pubmed: 12 1 2024
entrez: 12 1 2024
Statut: aheadofprint

Résumé

Characterizing the genetically diverse HIV sequences that persist in the reservoir despite antiretroviral therapy (ART) is critical to cure efforts. Our observations confirm that proviruses persisting in blood on ART, which are largely genetically defective, broadly reflect the extent of within-host HIV evolution pre-ART. Moreover, on-ART clonal expansion is not appreciably accompanied by the loss of distinct proviral lineages. In fact, on-ART proviral genetic composition remained stable in all but one participant, in whom, after 12 years on ART, proviruses dating to around near ART initiation had been preferentially eliminated. We also identified recombinant proviruses between parental sequence fragments of different ages. Though rare, such sequences suggest that reservoir cells can be superinfected with HIV from another infection era. Overall, our finding that the replication-competent reservoir in blood is a genetically restricted, younger subset of all persisting proviruses suggests that HIV cure strategies will need to eliminate a reservoir that differs in key respects from the overall proviral pool.

Identifiants

pubmed: 38214547
doi: 10.1128/jvi.01655-23
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0165523

Investigateurs

Ighovwerha Ofotokun (I)
Anandi Sheth (A)
Gina Wingood (G)
Todd Brown (T)
Joseph Margolick (J)
Kathryn Anastos (K)
David Hanna (D)
Anjali Sharma (A)
Deborah Gustafson (D)
Tracey Wilson (T)
Gypsyamber D'Souza (G)
Stephen Gange (S)
Elizabeth Topper (E)
Mardge Cohen (M)
Audrey French (A)
Steven Wolinsky (S)
Frank Palella (F)
Valentina Stosor (V)
Bradley Aouizerat (B)
Jennifer Price (J)
Phyllis Tien (P)
Roger Detels (R)
Matthew Mimiaga (M)
Seble Kassaye (S)
Daniel Merenstein (D)
Maria Alcaide (M)
Margaret Fischl (M)
Deborah Jones (D)
Jeremy Martinson (J)
Charles Rinaldo (C)
Mirjam-Colette Kempf (MC)
Jodie Dionne-Odom (J)
Deborah Konkle-Parker (D)
James B Brock (JB)
Adaora Adimora (A)
Michelle Floris-Moore (M)

Auteurs

Aniqa Shahid (A)

Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada.
British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.

Signe MacLennan (S)

Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada.

Bradley R Jones (BR)

British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.
Bioinformatics Program, University of British Columbia, Vancouver, British Columbia, Canada.

Hanwei Sudderuddin (H)

British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.

Zhong Dang (Z)

British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.

Kyle Cobarrubias (K)

British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.

Maggie C Duncan (MC)

Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada.
British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.

Natalie N Kinloch (NN)

Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada.
British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.

Michael J Dapp (MJ)

Department of Microbiology, University of Washington, School of Medicine, Seattle, Washington, USA.

Nancie M Archin (NM)

UNC HIV Cure Center, Institute of Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

Margaret A Fischl (MA)

Department of Medicine, University of Miami School of Medicine, Miami, Florida, USA.

Igho Ofotokun (I)

Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.

Adaora Adimora (A)

Department of Epidemiology, UNC Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

Stephen Gange (S)

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

Bradley Aouizerat (B)

College of Dentistry, New York University, New York, New York, USA.

Mark H Kuniholm (MH)

Department of Epidemiology and Biostatistics, University at Albany, State University of New York, Rensselaer, New York, New York, USA.

Seble Kassaye (S)

Division of Infectious Diseases and Tropical Medicine, Georgetown University, Washington, DC, USA.

James I Mullins (JI)

Department of Microbiology, University of Washington, School of Medicine, Seattle, Washington, USA.
Department of Global Health, University of Washington, School of Medicine, Seattle, Washington, USA.
Department of Medicine, University of Washington, School of Medicine, Seattle, Washington, USA.

Harris Goldstein (H)

Departments of Microbiology and Immunology and Pediatrics, Albert Einstein College of Medicine, Bronx, New York, New York, USA.

Jeffrey B Joy (JB)

British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.
Bioinformatics Program, University of British Columbia, Vancouver, British Columbia, Canada.
Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

Kathryn Anastos (K)

Department of Medicine, Albert Einstein College of Medicine, New York, New York, USA.

Zabrina L Brumme (ZL)

Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada.
British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.

Classifications MeSH